P. A. Reece

405 total citations
14 papers, 335 citations indexed

About

P. A. Reece is a scholar working on Pediatrics, Perinatology and Child Health, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. A. Reece has authored 14 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 3 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. A. Reece's work include Pharmacological Effects and Toxicity Studies (6 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Potassium and Related Disorders (2 papers). P. A. Reece is often cited by papers focused on Pharmacological Effects and Toxicity Studies (6 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Potassium and Related Disorders (2 papers). P. A. Reece collaborates with scholars based in Australia, United Kingdom and United States. P. A. Reece's co-authors include Irene Stafford, P. Grantley Gill, D. L. Barnard, D. F. SMEE, R. W. Sidwell, Simon P. Tucker, Keith G. Watson, Raymond G. Morris, Carryn M. Anderson and Richard L. Abbott and has published in prestigious journals such as Journal of Clinical Oncology, Biological Psychiatry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

P. A. Reece

14 papers receiving 318 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
P. A. Reece	139	101	78	63	40	14	335
Chlebowski Rt	43 0.3×	87 0.9×	60 0.8×	25 0.4×	27 0.7×	11	388
Gianluca Perego	64 0.5×	106 1.0×	92 1.2×	63 1.0×	38 0.9×	29	350
C. I. Backhouse	65 0.5×	100 1.0×	52 0.7×	34 0.5×	86 2.1×	30	374
Masahiro Matsui	47 0.3×	97 1.0×	65 0.8×	31 0.5×	54 1.4×	70	454
R Streuli	63 0.5×	32 0.3×	111 1.4×	26 0.4×	119 3.0×	40	412
Kaj Sundqvist	66 0.5×	81 0.8×	95 1.2×	34 0.5×	98 2.5×	19	440
Myke R. Green	43 0.3×	155 1.5×	81 1.0×	10 0.2×	31 0.8×	24	396
Fatemeh Shirafkan	52 0.4×	54 0.5×	89 1.1×	53 0.8×	14 0.3×	12	424
Ingrid Domke	89 0.6×	26 0.3×	75 1.0×	15 0.2×	23 0.6×	27	388
Ismet Aydogdu	30 0.2×	61 0.6×	46 0.6×	24 0.4×	40 1.0×	27	370

Countries citing papers authored by P. A. Reece

Since Specialization

Citations

This map shows the geographic impact of P. A. Reece's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. A. Reece with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. A. Reece more than expected).

Fields of papers citing papers by P. A. Reece

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. A. Reece. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. A. Reece. The network helps show where P. A. Reece may publish in the future.

Co-authorship network of co-authors of P. A. Reece

This figure shows the co-authorship network connecting the top 25 collaborators of P. A. Reece. A scholar is included among the top collaborators of P. A. Reece based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. A. Reece. P. A. Reece is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Barnard, D. L., D. F. SMEE, R. W. Sidwell, et al.. (2004). In Vitro Activity of Expanded-Spectrum Pyridazinyl Oxime Ethers Related to Pirodavir: Novel Capsid-Binding Inhibitors with Potent Antipicornavirus Activity. Antimicrobial Agents and Chemotherapy. 48(5). 1766–1772. 53 indexed citations

Reece, P. A. & H. Hird. (2000). Modification of the ion exchange HPLC procedure for the detection of nitrate and nitrite in dairy products. Food Additives & Contaminants. 17(3). 219–222. 10 indexed citations

Cutler, N.R., et al.. (1994). Maximally tolerated dose of the muscarinic agonist CI-979 in Alzheimer's disease (AD). Biological Psychiatry. 35(9). 628–628. 2 indexed citations

Reece, P. A., Irene Stafford, Richard L. Abbott, et al.. (1989). Two- versus 24-hour infusion of cisplatin: pharmacokinetic considerations.. Journal of Clinical Oncology. 7(2). 270–275. 50 indexed citations

Reece, P. A., et al.. (1987). Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity.. Journal of Clinical Oncology. 5(2). 304–309. 119 indexed citations

Reece, P. A., et al.. (1986). Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin.. Journal of Clinical Oncology. 4(9). 1392–1398. 38 indexed citations

Reece, P. A., et al.. (1985). Prednisolone protein binding in renal transplant patients.. British Journal of Clinical Pharmacology. 20(2). 159–162. 6 indexed citations

Reece, P. A., et al.. (1985). Synthesis, Formulation, and Clinical Pharmacological Evaluation of Hydralazine Pyruvic Acid Hydrazone in two Healthy Volunteers. Journal of Pharmaceutical Sciences. 74(2). 193–196. 8 indexed citations

Jones, Terry E., et al.. (1983). Mexiletine removal by peritoneal dialysis. European Journal of Clinical Pharmacology. 25(6). 839–840. 10 indexed citations

10.

Reece, P. A., et al.. (1983). Endralazine ? A new hydralazine-like antihypertensive with high systemic bioavailability. European Journal of Clinical Pharmacology. 25(4). 553–556. 1 indexed citations

11.

Zacest, R. & P. A. Reece. (1982). Intravenous administration of hydrallazine. The Medical Journal of Australia. 1(12). 497–498. 2 indexed citations

12.

Reece, P. A., et al.. (1982). Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator antihypertensive, endralazine. European Journal of Clinical Pharmacology. 23(6). 523–527. 8 indexed citations

13.

Schapel, Graham J., Roy G. Beran, C. J. Doecke, et al.. (1980). Pharmacokinetics of sodium valproate in epileptic patients: Prediction of maintenance dosage by single-dose study. European Journal of Clinical Pharmacology. 17(1). 71–77. 14 indexed citations

14.

Reece, P. A., D. Tóth, & E. A. Dawes. (1976). Fermentation of Purines and their Effect on the Adenylate Energy Charge and Viability of Starved Peptococcus pravotii. Journal of General Microbiology. 97(1). 63–71. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact